Objectives: Estrogen and progesterone improve neurologic outcomes in experimental models of cardiac arrest and stroke. Our objective was to determine whether women of child-bearing age are more likely than men to survive to hospital discharge after inhospital cardiac arrest.
D uring 2005, Ͼ20,000 in-hospital cardiac arrests were reported in the American Heart Association's National Registry of Cardiopulmonary Resuscitation (NRCPR), a database representing approximately 10% of the hospitals in the United States. According to several studies, only 18% of adults with inhospital arrests survived to hospital discharge (1-3).
Survival rates may be related to genderassociated differences and possible hormonal factors (4 -11) . Estrogen and progesterone have been extensively studied as neuroprotective agents in animal models of global hypoxic-ischemic injury, stroke, and traumatic brain injury (12) (13) (14) (15) (16) (17) (18) (19) . In a pilot, controlled, clinical trial of progesterone administration in humans after traumatic brain injury, patients treated with progesterone were much more likely to survive to hospital discharge (20) . Accordingly, some experts have recently proposed the administration of estrogen and/or progesterone to improve outcomes from cerebral ischemic insults and cardiac arrest (CA) (21, 22) .
To further substantiate the postulate that female sex hormones may provide a survival advantage in CA, we compared outcomes between women and men after inhospital CA. Considering the average onset of menarche in the United States is 13 yrs of age (23) and the average age of menopause is 50 yrs (24) , we stratified inhospital CA victims into younger and older age categories based on a presumed differential of "female sex hormone exposure" in the younger population. It was presumed that women of child-bearing age or, specifically, those 15-44 yrs of age would have a high concentration of female sex hormone exposure relative to men. In turn, it was hypothesized that this younger cohort of women would be more likely to survive to hospital discharge than men of the same age. Conversely, we also hypothesized that survival differences between women and men would not be present for inhospital CA victims who are age 56 yrs or older, considering that high concentrations of sex hormone exposure generally would no longer be an important contributing factor.
MATERIALS AND METHODS
The study was conducted using the American Heart Association NRCPR database. The study design of the NRCPR has been described in detail (2) . The NRCPR is a multicenter, observational registry of inhospital CAs using predefined, standardized nomenclature and data set definitions. Data accuracy is achieved by trained data abstractors at each institution, case study methodology, and detailed periodic re-abstraction, with mean error rates for all of the data of 2.4% Ϯ 2.7%. The resultant database contains precisely defined variables based on Utstein-style data reporting guidelines for CA (25) . Explicit operational definitions have been generated for every data element.
This study was approved by the Institutional Review Board of The Children's Hospital of Philadelphia and the analysis included patients from 519 hospitals that provided data from January 1, 2000 through July 31, 2008.
All patients who experienced a pulseless CA requiring chest compressions, defibrillation, or both and eliciting a hospital-wide emergency resuscitation response resulting in the generation of a resuscitation record were eligible for inclusion. CA was defined as cessation of cardiac mechanical activity, determined by absence of central pulse, unresponsiveness, and apnea. Only the index pulseless event was included for each patient. An index event was defined as the first CA event for a patient during a hospitalization.
Events were excluded if they began out of hospital, occurred in obstetrical patients, or included defibrillation by an implantable cardioverter defibrillator. Patients who had "do not attempt resuscitation" orders before their inhospital CA were excluded from the registry. Patients without age, gender, or survival data were excluded. If a hospital had Ͼ90% of CAs occurring in one gender (women or men), then the patients and hospital were excluded to minimize hospital level bias on gender. This resulted in exclusion of 33 hospitals.
To minimize the risk of misclassification bias with respect to potential female sex hormone exposure, patients younger than 15 yrs and those 45-55 yrs of age were excluded from the analysis. It was judged that women in this latter age group may have variable levels of hormone exposure. Therefore, the defined exposure groups used for comparison were women 15-44 yrs of age, a cohort with presumed high concentrations of endogenous female sex hormones, and three cohorts presumed to be without high concentrations of female sex hormones: men 15-44 yrs, women 56 yrs or older, and men 56 yrs or older.
The prospectively defined primary outcome measurement was survival to hospital discharge (25) . Secondary outcomes included return of spontaneous circulation lasting Ͼ20 mins and favorable neurologic outcome. Favorable neurologic outcome was determined using the cerebral performance category score for patients age 18 yrs or older and the pediatric cerebral performance category score for patients younger than 18 yrs old (26) . Neurologic outcome was categorized as a binomial outcome of favorable (cerebral performance category 1, 2, or unchanged from admission) or unfavorable outcome (cerebral performance category 3, 4, 5, or worse than admission) (2, 27) .
Unadjusted analyses were used to evaluate baseline differences between the four patient groups. Covariates and potential confounders were compared across the four populations to describe differences in distribution clustered within hospitals.
Summary statistics and analyses for the number of epinephrine doses and duration of CA were stratified by age and gender groups and are reported as median and interquartile ranges. The variables were analyzed using Cox regression (number of epinephrine doses) or linear regression (duration of arrest). Processof-care variables were not included in the multivariable model because they occurred after the exposure of interest.
Fixed-effects linear regression (conditioning on hospital) was used to examine the relationship between age and gender groups and survival outcomes to control for potential confounding by hospital. Outcomes varied across hospitals, as did the age-gender groups. We used linear rather than logistic regression because the large number of observations per hospital exceeded the capabilities of conventional conditional logistic algorithms and because the expected probabilities (of outcome) were close to neither 0.0 nor 1.0. Using conditional regression, the resulting estimates of the association of age-gender categories and outcome are "withinhospital" estimates, not confounded by differences across hospitals in the age and gender of patients (28) . This methodology also controls for any other unobserved hospital characteristics that might confound the observed results by influencing the hospital-level outcome rates.
Patient-level potential confounders including a priori covariates based on previous NRCPR publications were: race, Hispanic ethnicity, arrest time of day, arrest day of week (weekend vs. weekday), first documented electrocardiogram rhythm, discovery status (witnessed and/or monitored), illness category, and event location (29) . Hispanic ethnicity was a patient selfassigned categorization obtained from chart abstraction. Illness category was assigned to describe the primary reason for hospitalization: medical vs. surgical and cardiac vs. noncardiac. A continuous variable of the difference between a subject's age and the mean for the age-gender category was included in the regression model to control for any residual age confounding not already captured by category.
The association between age and gender categories and outcomes were assessed, adjusting in all cases for a priori potential confounders of interest. Additional potential confounders were introduced sequentially into each multivariable model to detect whether they influenced the coefficients of interest. If the coefficients did not change and the factor did not have a significant association with outcome, then that covariate was not included in the final model. If the covariate was not a confounder but was statistically significant, then we included it in the model to improve the efficiency of our estimates of association of the factors of interest and outcome. Additional covariates added to the final model were preexisting conditions, therapies already in place before arrest, and causes of arrest. They are listed in Tables 1 and 2 .
Although, fixed-effects (conditional) regression controlled for all hospital-level factors, they did not consider whether the adjusted associations of interest (age-gender and outcome) might vary across hospitals. For that reason, we resampled hospitals using 999 bootstrap samples and calculated bias-corrected (30) confidence intervals to ensure that measure of uncertainty accounted for the possibility of variation in risk differences across the hospitals. These confidence bounds differed only slightly from regression-based confidence intervals and are more conservative. Thus, results are reported as absolute risk reduction and bootstrap analysis confidence intervals. Because initial rhythm is a wellknown potential confounder, we performed as a sensitivity analysis separate regression for asystole/pulseless electrical activity and ventricular fibrillation/pulseless ventricular tachycardia.
All p values represent two-sided hypothesis tests. The significance level for all tests was ␣ ϭ .05. Statistical analysis was performed using Stata 10.1 (College Station, TX).
The NRCPR data from previous studies indicate that 17% of men 15-44 yrs of age survive to hospital discharge. Accordingly, it The p refer to the differences across the four populations clustered within hospitals by Wald test. Factors modeled but not included were immediate causes of event of pulmonary embolism, pulmonary edema, and mode of event discovery. The p refers to the differences across the four populations clustered within hospitals by Wald test. Factors modeled but not included were races Asian/Pacific Islander, Eskimo, and other; preexisting conditions of congestive heart failure (preadmission), baseline central nervous system depression, acute stroke, acute central nervous system nonstroke event, and none; and interventions in place of pulse oximeter, apnea bradycardia monitor, intra-aortic balloon pump, pulmonary artery catheter, and none.
was determined that a sample size of 11,782 would be required using an alpha value of 0.05 and a power of 0.8 to detect an absolute survival difference of 2% between men and women 15-44 yrs of age, translating into a relative survival difference of Ͼ10%.
RESULTS
During the study period, 143,084 consecutive CA events were reported from 519 hospitals. There were 119,879 index CA events. After applying the inclusion and exclusion criteria, 95,852 analyzable subjects remained. These subjects were stratified by age and gender ( Fig. 1 ).
There were large differences in covariates stratified by age and gender groups (Table 1 ). Subjects 56 yrs or older had higher percentages of white race, whereas subjects 15-44 yrs old had higher percentages of black race. Both women and men 56 yrs or older had higher prevalences of congestive heart failure, myocardial infarction, and diabetes mellitus than patients 15-44 yrs old. The younger patients (men and women 15-44 yrs) had a higher prevalence of mechanical ventilation before arrest. The younger males had a higher prevalence of pre-existing trauma than the subjects in the other three age/gender categories.
Patient arrest characteristics also differed significantly across all four age groups, except for stroke and status epilepticus, as described in Table 2 . Patients younger than 45 yrs (9%) were less likely to have an arrest on a monitored in-patient unit than were patients 56 yrs or older (20%; p Ͻ .001). Seventy percent of patients had a monitored and witnessed event and there was no difference between age and gender groups (p ϭ .77). There was no difference in the number of epinephrine doses administered to survivors ( Table 3) .
Of all 95,852 patients, 47,993 (50%) survived the event, 17,410 (18%) survived to discharge, and 13,244 (14%) had a favorable neurologic outcome. Unadjusted out-come data are shown in the Figure and adjusted outcome data are summarized in Table 4 . After conditioning on hospital and adjusting for patient and arrest characteristics (Tables 1 and 2) , younger women had an absolute 2.8% (95% confidence interval, 1% to 4.6%; p ϭ .002) higher rate of survival to hospital discharge than did younger men. In contrast, there was no demonstrable difference in survival to discharge rates between older women and men (Ϫ0.1%; 95% confidence interval, Ϫ0.9% to 0.6%; p ϭ .68). Women 15 to 44 yrs of age had an absolute 2.6% higher rate of survival with a favorable neurologic outcome (95% confidence interval, 0.9% to 4.3%; p ϭ .002) compared to men of the same age, whereas again there was no demonstrable difference in survival with a favorable neurologic outcome when comparing the older women and men (Ϫ0.l %; 95% confidence interval, Ϫ0.7% to 0.5%; p ϭ .74). A sensitivity analysis was performed by initial rhythm of pulseless electrical activity/asystole and ventricular fibrillation/pulseless ventricular tachycardia and showed no difference in the point estimates for survival to discharge compared to the regression model controlling for initial pulseless rhythm.
DISCUSSION
These data establish that after inhospital CA, women of child-bearing age (15-44 yrs old) were more likely to survive to hospital discharge than were men in the same age range. In addition, the 15-to 44-yr-old women were more likely to survive with favorable neurologic outcome. In contrast, there were no demonstrable differences in these outcomes between the cohort of older women and men 56 yrs of age or older.
Our data indicate that the survival advantage of 15-to 44-yr-old women vs. 15to 44-yr-old men is substantial. Our estimated absolute difference in outcomes translates to a 17% relative increase in survival to discharge and a 21% relative increase in survival with favorable neurologic outcome for women 15 to 44 yrs old. These improvements exceed the absolute and relative improvements in survival from many highly publicized major advances in healthcare, such as adherence to acute myocardial infarction guidelines and interventions to decrease infections associated with central venous catheters (31) (32) (33) . Because Ͼ20,000 inhospital CAs are reported to the NRCPR each year from approximately 10% of U.S. hospitals, these absolute and relative outcome differences affect a substantial number of patients. If this difference is attributable to female sex hormones and administration of female sex hormones after injury could improve outcomes to this extent or better, then tens of thousands of lives may be affected positively.
Both experimental and clinical investigations support the biological plausibility of the concept that female hormones can improve outcomes from global cerebral hypoxic-ischemic insults (12, 13, 15-20, 34 -36) . Although several diverse mechanisms of action have been proposed, it is clear that the protective effects of female hormones, such as estrogen, are not receptor-site specific but rather have impact across multiple cellular lines, thus affording benefit for both males and females (22) . Recent human interventional trials suggest that postinjury exogenous progesterone treatment may improve outcome after traumatic brain injury (20, 36) . Thus far, no human intervention trials evaluating the administration of estrogen or progesterone after CA have been published.
Both prospective and retrospective observational clinical studies suggest that women are more likely to survive to hospital admission than men after out-ofhospital CAs (4, 10 -11, 35) . This difference persists especially when controlling for age and despite the increased prevalence of asystole (a less favorable rhythm) in women (10) . Despite this apparent improvement in rates of successful initial resuscitation, these studies were unable to demonstrate improvement in survival to discharge, either because of study design or because of inadequate power. Importantly, the epidemiology and outcomes after outof-hospital CA differ from inhospital CA.
In a recent study showing no improvement in survival from 1992 to 2005 among Ͼ400,000 inhospital CAs in a Medicare administrative database (older than 65 yrs old), men had a lower survival rate than women (37) . Whereas these data may appear to conflict with our results, that study did not adjust for potential confounders of the relationship between gender and outcome, including initial rhythm, event location, and asso- ciated acute medical conditions. In contrast, we specifically controlled for known confounders and interactions between age and gender that modify the covariate relationship with outcome.
With the large data set afforded by the NRCPR, the current study was adequately powered to detect a difference in the rate of hospital discharge (our prospectively designated primary outcome). In addition, this study was adequately powered to demonstrate an improved rate of favorable neurologic outcome for the women 15-44 yrs of age (our prospectively designated secondary outcome).
Nevertheless, the basis for this association is limited and cannot be fully confirmed by this observational database. Although we hypothesized that such differences would occur because of protection from high concentrations of female hormones, the increased survival among younger women might be attributable to other factors, such as pre-arrest risk-taking behaviors, gender-related differences in anatomy, or gender-related differences in the care patients receive before, during, and after CA. For example, chest wall compliance and recoil during chest compression may be different for men and women. Conversely, women and blacks are less likely to receive certain interventions after acute myocardial infarction (38, 39) . It is possible that gender-related process-of-care differences that are not reported to the NRCPR also occur during cardiopulmonary resuscitation and/or after resuscitation. Nevertheless, it is notable that the outcome differences in our study were only demonstrated for women of child-bearing age, 15 to 44 yrs old, but not for women older than 56 yrs of age.
As with all multicenter registries, the database used in this study has potential limitations related to integrity and validity of the data. However, the rigorous abstractor-training process, uniform data collection, consistent definitions, detailed periodic re-abstraction process, and the large sample were implemented prospectively to address the issues of validity and integrity.
The variability in resuscitative and postresuscitative processes of care between multiple institutions raises the concern that a true treatment effect may be confounded by institutional practice (40) . To help address this potential limitation, hospitals that treated more than 90% men or women were excluded. Most importantly, hospital-level factors were controlled for in our analysis using fixed-effects regression.
We categorized our patients' age on the presumed high concentrations of sex hormones. Menarche and menopause have onsets at different times for each woman. In the United States, the average onset of menstruation is 13 yrs old (23) and the average onset of menopause is 50 yrs old (24) . Therefore, to minimize the risk of misclassification bias, we specifically excluded patients younger than 15 yrs old and those between 45 and 55 yrs old from the analysis. History regarding oral contraceptive use, exogenous hormonal supplementation, tamoxifen use, and the onset of premature menopause was not available. In addition, estrogen and progesterone levels were not measured in these patients.
To account for our findings, future studies to assess the role of gender-specific process-of-care variables and hormonal effects on the association between gender and CA survival are necessary. To address the lack of patient-specific hormonal data in this study, a prospective evaluation of estrogen and progesterone levels in patients who experience CA should be performed. Conditions that affect endogenous hormonal levels (e.g., anorexia, bulimia, polycystic ovarian syndrome), exogenous hormone levels (e.g., contraceptives, tamoxifen), and measured hormonal levels accounting for the effects of one specific hormone (estrogen or progesterone) or their combination should be accounted for to evaluate their impact on survival.
CONCLUSION
In this multicenter registry of inhospital CAs, women of child-bearing age were more likely to survive to hospital discharge and survive with favorable neurologic outcome compared with age-matched men, even after controlling for etiology of arrest and important measurable patient, event, and hospital variables. This survival benefit was not present for women 56 yrs old or older (presumed postmenopausal) compared to the age-matched men. Delineation of the mechanisms of younger women's survival advantage may result in new strategies to improve outcomes for victims of CAs.
